Despite the initial response rate to anti-inflammatory therapy in patients with systemic lupus erythematosus with serositis, relapses remain common; belimumab is linked to a lower risk for relapse.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/belimumab-linked-lower-relapse-risk-patients-lupus-related-2026a1000gm3?src=rss
Author :
Publish date : 2026-05-25 12:00:00
Copyright for syndicated content belongs to the linked Source.
